ACERUS PHARMACEUTICALS
Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the field of men’s health. The Company commercializes its products via its own salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
ACERUS PHARMACEUTICALS
Social Links:
Industry:
Clinical Trials Medical Pharmaceutical
Founded:
2008-01-01
Address:
Mississauga, Ontario, Canada
Country:
Canada
Website Url:
http://www.aceruspharma.com
Total Employee:
1+
Status:
Active
Total Funding:
48.17 M USD
Technology used in webpage:
SPF Google Tag Manager Google Maps Content Delivery Network Global Site Tag IPv6 Cloudflare Hosting Microsoft Exchange Online Office 365 Mail Cloudflare CDN
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Synthon Chiragenics Corp.
Synthon Chiragenics Corp. is a world-leader in carbohydrate-based chiral technology for pharmaceuticals
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-03-07 | Serenity Pharmaceuticals | Serenity Pharmaceuticals acquired by Acerus Pharmaceuticals | N/A |
Investors List
First Generation Capital
First Generation Capital investment in Post-IPO Debt - Acerus Pharmaceuticals
First Generation Capital
First Generation Capital investment in Post-IPO Debt - Acerus Pharmaceuticals
First Generation Capital
First Generation Capital investment in Post-IPO Equity - Acerus Pharmaceuticals
First Generation Capital
First Generation Capital investment in Post-IPO Debt - Acerus Pharmaceuticals
Quantius
Quantius investment in Post-IPO Debt - Acerus Pharmaceuticals
Official Site Inspections
http://www.aceruspharma.com Semrush global rank: 10.57 M Semrush visits lastest month: 220
Unable to get host informations!!!
More informations about "Acerus Pharmaceuticals"
Acerus Pharmaceuticals - Crunchbase Company Profile …
Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a …See details»
Acerus Pharma - LinkedIn
Acerus Pharma | 3,220 followers on LinkedIn. Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the development, …See details»
Acerus Pharmaceuticals - PitchBook
Acerus Pharmaceuticals General Information Description. Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and …See details»
CCAA Records Acerus Pharmaceuticals Corporation
Companies’ Creditors Arrangement Act record for Acerus Pharmaceuticals Corporation.See details»
Overview, News & Similar companies - ZoomInfo.com
Mar 14, 2023 Who is Acerus Pharmaceuticals. Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and …See details»
Acerus Announces Definitive Agreement to Acquire Serenity LLC …
Feb 28, 2022 Importantly, and despite the impact of COVID-19, Acerus has built a robust commercial organization in the United States that has driven Natesto ® total prescription …See details»
Acerus Pharmaceuticals - Craft
Mar 3, 2023 Acerus Pharmaceuticals has 5 employees across 2 locations and ($4.13 m) in annual revenue in FY 2021. See insights on Acerus Pharmaceuticals including office locations, …See details»
Acerus Buys Back All Remaining U.S. Rights for NATESTO® From …
Company [email protected] Investor Relations ContactChris WittyAcerus Investor Relations (646) [email protected]. Acerus Assumes Full NATESTO Ownership …See details»
Acerus Announces Initiation of Strategic Review
TORONTO, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX: ASP; OTCQB: ASPCF) …See details»
Acerus Files For CCAA Protection - Yahoo Finance
TORONTO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced that the Company …See details»
Expanded U.S. NATETSO - Business Wire
Dec 2, 2019 To establish a high performing commercial footprint in the U.S., Acerus has engaged Syneos Health (NASDAQ: SYNH), a leading integrated biopharmaceutical solutions …See details»
Acerus Announces Definitive Agreement to Acquire Serenity
Feb 28, 2022 Importantly, and despite the impact of COVID-19, Acerus has built a robust commercial organization in the United States that has driven Natesto ® total prescription …See details»
Acerus Announces Closing of Acquisition of Serenity
Mar 7, 2022 For more information, visit www.aceruspharma.com and follow us on Twitter and LinkedIn. About Serenity. Founded in 2006 and located in Miami, Florida, Serenity …See details»
Acerus Update - GlobeNewswire
TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- As announced on January 26, 2023, Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) and its...See details»
Acerus Announces Closing of Acquisition of Serenity …
Mar 7, 2022 Acerus will host an investor call to discuss the acquisition of Serenity on March 9, 2022 at 8:30 am Eastern. To access the call live, please dial 416-406-0743 or 1-800-952-5114 …See details»
Acerus Announces Definitive Agreement to Acquire Serenity LLC …
Creating a Leading Urology & Men’s Health Pharmaceutical Company Acerus to have access to two significant and growing addressable markets that represent more than 40 million people in …See details»
Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed ... - Seeking …
May 14, 2021 Acerus Pharmaceuticals Corporation (ASPCF) Q1 2021 Results Conference Call May 13, 2021 10:00 AM ETCompany ParticipantsBob Motz - CFOEd Gudaitis - President...See details»
Acerus Announces Commencement of Court-Approved Sale and
TORONTO, March 14, 2023 (GLOBE NEWSWIRE) -- On January 26, 2023, Acerus Pharmaceuticals Corporation and certain of its subsidiaries (collectively,...See details»
ACERUS PHARMA – ACERUS PHARMA
Acerus Pharmaceuticals is a rapidly growing pharmaceutical company Acerus is committed to addressing unmet medical needs and improving the lives of patients worldwide.See details»
Abortion pill access requests surge from U.S., Canadian non-profit …
1 day ago The Canadian non-profit organization provides online consultation and medication for women around the world seeking abortion says it has seen a fourfold increase in U.S. …See details»